HER4 Promotes Osteosarcoma Progression and Predicts Poor Prognosis through the PTEN-PI3K/AKT Pathway: Retraction

Ma, Kun; Zhang, Chuan

doi:10.7150/jca.110321

Top

International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

open access Global reach, higher impact

PDF

J Cancer 2025; 16(4):1347. doi:10.7150/jca.110321 This issue Cite

Retraction

HER4 Promotes Osteosarcoma Progression and Predicts Poor Prognosis through the PTEN-PI3K/AKT Pathway: Retraction

Kun Ma^*, Chuan Zhang^*

Luoyang Orthopaedic Hospital of Henan Province & Orthopaedic Hospital of Henan Province, Luoyang, Henan 471002, China.
* Contributed equally

Citation:

Ma K, Zhang C. HER4 Promotes Osteosarcoma Progression and Predicts Poor Prognosis through the PTEN-PI3K/AKT Pathway: Retraction. J Cancer 2025; 16(4):1347. doi:10.7150/jca.110321. https://www.jcancer.org/v16p1347.htm

Other styles

Retracted-article in J Cancer, Volume 13, 290

We, the authors, would like to retract our paper entitled “HER4 Promotes Osteosarcoma Progression and Predicts Poor Prognosis through the PTEN-PI3K/AKT Pathway” due to concerns on image duplications. We would like to express apology for our negligence and mistakes in this paper.

Author contact

Corresponding author: Kun Ma, Luoyang Orthopaedic-Traumatological Hospital & Orthopaedic Hospital of Henan Province, 82 QiMing Road, Luoyang, Henan 471002, China E-mail: makuncn

Published 2025-1-16

Citation styles

APA

Ma, K., Zhang, C. (2025). HER4 Promotes Osteosarcoma Progression and Predicts Poor Prognosis through the PTEN-PI3K/AKT Pathway: Retraction. Journal of Cancer, 16(4), 1347. https://doi.org/10.7150/jca.110321.

ACS

Ma, K.; Zhang, C. HER4 Promotes Osteosarcoma Progression and Predicts Poor Prognosis through the PTEN-PI3K/AKT Pathway: Retraction. J. Cancer 2025, 16 (4), 1347. DOI: 10.7150/jca.110321.

NLM

CSE

Ma K, Zhang C. 2025. HER4 Promotes Osteosarcoma Progression and Predicts Poor Prognosis through the PTEN-PI3K/AKT Pathway: Retraction. J Cancer. 16(4):1347.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.